Valuation: AbbVie Inc.

Market Cap 438B 384B 356B 328B 619B 41,938B 632B 4,242B 1,664B 20,595B 1,645B 1,609B 71,124B P/E 2026 *
30.7x
P/E 2027 * 23.3x
Enterprise Value 495B 434B 402B 370B 699B 47,335B 713B 4,788B 1,878B 23,245B 1,857B 1,816B 80,277B EV / Sales 2026 *
7.36x
EV / Sales 2027 * 6.68x
Free-Float
95.71%
Yield 2026 *
2.77%
Yield 2027 * 2.92%
1 day-0.03%
1 week-2.65%
Current month-1.45%
1 month+8.90%
3 months+20.11%
6 months+12.34%
Current year+8.54%
1 week 244.61
Extreme 244.6101
255.82
1 month 215.37
Extreme 215.37
261.64
Current year 190.75
Extreme 190.75
261.64
1 year 184.63
Extreme 184.63
261.64
3 years 134.56
Extreme 134.5609
261.64
5 years 105.56
Extreme 105.56
261.64
10 years 55.06
Extreme 55.0623
261.64
Manager TitleAgeSince
Chief Executive Officer 55 2024-06-30
Director of Finance/CFO 59 2022-06-22
Chief Tech/Sci/R&D Officer - 2024-02-29
Director TitleAgeSince
Director/Board Member 65 2012-12-31
Director/Board Member 74 2012-12-31
Director/Board Member 68 2012-12-31
Date Insider Type Main position Quantity % Market Cap.
Jun. 29Free

Director

62 0.0000%
Jun. 29Free

Director

134 0.0000%
May. 07Free

Director

1,118 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.03%-2.65%+28.86%+85.64% 438B
-0.56%-1.52%+49.04%+171.88% 1,060B
+0.31%-0.60%+64.29%+62.31% 619B
-1.75%-0.33%+28.78%+23.58% 333B
+0.24%-0.42%+29.46%+47.26% 282B
-1.75%-10.57%+20.67%+22.07% 267B
+0.67%+1.03%-26.10%-37.96% 218B
-0.81%-1.63%+22.07%+58.33% 196B
+1.21%+1.38%+19.85%+71.29% 161B
+1.28%+3.20%-4.56%-32.11% 138B
Average -0.06%-1.78%+23.24%+47.23% 371.17B
Weighted average by Cap. -0.21%-1.92%+34.76%+79.63%

Financials

2026 *2027 *
Net sales 67.23B 58.97B 54.62B 50.25B 95.05B 6,435B 96.9B 651B 255B 3,160B 252B 247B 10,913B 72.79B 63.84B 59.13B 54.41B 103B 6,967B 105B 705B 276B 3,421B 273B 267B 11,815B
Net income 14.58B 12.79B 11.84B 10.9B 20.61B 1,395B 21.01B 141B 55.36B 685B 54.75B 53.55B 2,367B 19B 16.66B 15.43B 14.2B 26.86B 1,818B 27.38B 184B 72.14B 893B 71.34B 69.78B 3,084B
Net Debt 56.39B 49.46B 45.81B 42.15B 79.72B 5,397B 81.27B 546B 214B 2,650B 212B 207B 9,153B 47.87B 41.99B 38.89B 35.78B 67.69B 4,582B 69B 464B 182B 2,250B 180B 176B 7,771B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
26-07-13 $248.00 -0.03% 4,156,363
26-07-10 $248.08 -0.73% 5,780,990
26-07-09 $249.91 -1.12% 5,526,006
26-07-08 $252.74 -0.75% 7,578,707
26-07-07 $254.65 -0.04% 8,238,267
Trader
Investor
Global
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
248.00USD
Average target price
265.50USD
Spread / Average Target
+7.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBV Stock